MASH Matters: Multidisciplinary Strategies for Translating the Latest Evidence Into Practice
Webinar/Online
Tuesday, January 28, 2025 at 9:00am ET - 10:00am ET
Add this event to your calendar
Info
Topic
Join our expert-led roundtable webinar where 3 leading specialists will discuss the pathophysiology of metabolic dysfunction–associated steatohepatitis (MASH) and explore effective, evidence-based approaches for diagnosis, treatment, and management. Learn how to integrate the latest research findings and multidisciplinary strategies into individualized treatment plans, focusing on improving patient outcomes in the context of related cardiometabolic comorbidities.
Credits Offered
This event offers
1.0 CE credit
to attendees.
Accreditation Info:
ANCC.
Additional Information
Who Should Attend
This program is intended for gastroenterologists, hepatologists, endocrinologists, diabetologists, primary care physicians, nurse practitioners, physician associates, and other healthcare professionals involved in the care of patients with metabolic dysfunction–associated steatotic liver disease (MASLD)/metabolic dysfunction–associated steatohepatitis (MASH).
Goal Statement
The goal of this program is to improve the knowledge and competence of learners in effort to optimize treatment for patients with MASLD and MASH.
Target Audience
This program is intended for gastroenterologists, hepatologists, endocrinologists, diabetologists, primary care physicians, nurse practitioners, physician associates, and other healthcare professionals involved in the care of patients with metabolic dysfunction–associated steatotic liver disease (MASLD)/metabolic dysfunction–associated steatohepatitis (MASH).
Learning Objectives
Upon completion of this activity, participants should be able to:
- Compare with pathophysiology of MASH with available and emerging treatment targets
- Employ recommended non-invasive testing methods and biomarkers to diagnose, stage, and monitor patients with MASLD/MASH
- Evaluate the efficacy and safety data for current and emerging treatments for MASH and outcomes on related cardiometabolic comorbidities
- Develop individualized treatment plans based on the latest evidence, comorbidities, and guideline recommendations for patients with MASLD/MASH
- Recognize the role of multidisciplinary team members in the comprehensive management of MASLD/MASH
Speakers
Chief, Division of Endocrinology, Diabetes and Metabolism
The University of Florida
Gainesville, Florida
Professor of Medicine
Houston Methodist Hospital
Director
Houston Research Institute
Houston, Texas
Professor and Diabetologist
Department of Clinical Sciences and Community Health
Touro University California
Vallejo, CA